{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:05:18Z","timestamp":1792670718183,"version":"4.5.0"},"reference-count":16,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMJ"],"DOI":"10.4274\/mmj.galenos.2023.85520","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T09:11:19Z","timestamp":1678439479000},"page":"63-69","source":"Crossref","is-referenced-by-count":4,"title":["The Effect of Platelet and Mean Platelet Volume Levels on Standard-dose Methylprednisolone Treatment Response in Primary Immune Thrombocytopenia"],"prefix":"10.4274","volume":"38","author":[{"given":"Emrah","family":"KILICASLAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"YILDIRIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"SAYIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"CEVIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"AYLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Kursat","family":"KAPTAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","unstructured":"1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386-93","journal-title":"Blood"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","unstructured":"2. Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829-66","journal-title":"Blood Adv"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/s-0039-1684031","article-title":"First-Line Therapy for Immune Thrombocytopenia","volume":"39","author":"Mithoowani","year":"2019","unstructured":"3. Mithoowani S, Arnold DM. First-Line Therapy for Immune Thrombocytopenia. Hamostaseologie. 2019;39:259-65","journal-title":"Hamostaseologie"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","article-title":"Platelet size: measurement, physiology and vascular disease","volume":"7","author":"PM","year":"1996","unstructured":"4. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157-61.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.4081\/hr.2019.7732","article-title":"The use of mean platelet volume for distinguishing the causes of thrombocytopenia in adult patients","volume":"11","author":"Norrasethada","year":"2019","unstructured":"5. Norrasethada L, Khumpoo W, Rattarittamrong E, Rattanathammethee T, Chai-Adisaksopha C, Tantiworawit A. The use of mean platelet volume for distinguishing the causes of thrombocytopenia in adult patients. Hematol Rep. 2019;11:7732","journal-title":"Hematol Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1365-2257.2005.00726.x","article-title":"Platelet size has diagnostic predictive value in patients with thrombocytopenia","volume":"27","author":"Bowles","year":"2005","unstructured":"6. Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol. 2005;27:370-3","journal-title":"Clin Lab Haematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3906\/sag-1912-242","article-title":"Mean platelet volume and response to the first line therapy in newly diagnosed adult immune thrombocytopenia patients: a retrospective study","volume":"50","author":"Akku\u015f","year":"2020","unstructured":"7. Akku\u015f E, Fidan \u00c7, Demirci G, Ku\u015fta\u015f AA, Y\u00fcksel M. Mean platelet volume and response to the first line therapy in newly diagnosed adult immune thrombocytopenia patients: a retrospective study. Turk J Med Sci. 2020;50:798-803","journal-title":"Turk J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.autrev.2014.01.026","article-title":"Diagnosis and classification of immune-mediated thrombocytopenia","volume":"13","author":"Lo","year":"2014","unstructured":"8. Lo E, Deane S. Diagnosis and classification of immune-mediated thrombocytopenia. Autoimmun Rev. 2014;13:577-83","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1182\/blood-2004-12-4598","article-title":"How I treat idiopathic thrombocytopenic purpura (ITP)","volume":"106","author":"DB","year":"2005","unstructured":"9. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005;106:2244-51","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Mithoowani S, Gregory-Miller K, Goy J, et al. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol. 2016;3:e489-96","DOI":"10.1016\/S2352-3026(16)30109-0"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3904\/kjim.2015.070","article-title":"Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia","volume":"34","author":"Kim","year":"2019","unstructured":"11. Kim CH, Choi YS, Moon JY, et al. Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia. Korean J Intern Med. 2019;34:383-9","journal-title":"Korean J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3109\/09537104.2013.845875","article-title":"Megakaryocyte morphology and its impact in predicting response to steroid in immune thrombocytopenia","volume":"25","author":"Tripathi","year":"2014","unstructured":"12. Tripathi AK, Mishra S, Kumar A, Yadav D, Shukla A, Yadav Y. Megakaryocyte morphology and its impact in predicting response to steroid in immune thrombocytopenia. Platelets. 2014;25:526-31","journal-title":"Platelets"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4274\/imj.galenos.2018.76158","article-title":"Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients","volume":"20","author":"Eren","year":"2019","unstructured":"13. Eren R, \u00dcnald\u0131 M, Kar\u0131\u015fmaz A, et al. Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients. Istanbul Medical Journal. 2019;20:54-7.","journal-title":"Istanbul Medical Journal"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12185-020-02847-4","article-title":"Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes","volume":"111","author":"Oka","year":"2020","unstructured":"14. Oka S, Ono K, Nohgawa M. Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes. Int J Hematol. 2020;111:771-8","journal-title":"Int J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Samson M, Fraser W, Lebowitz D. Treatments for Primary Immune Thrombocytopenia: A Review. Cureus. 2019;11:e5849","DOI":"10.7759\/cureus.5849"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/ajh.25275","article-title":"Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia","volume":"93","author":"Al-Samkari H","year":"2018","unstructured":"16. Al-Samkari H, Kuter DJ. Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol. 2018;93:1501-8.","journal-title":"Am J Hematol"}],"container-title":["Medeniyet Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:04:03Z","timestamp":1775541843000},"score":1,"resource":{"primary":{"URL":"https:\/\/medeniyetmedicaljournal.org\/articles\/doi\/MMJ.galenos.2023.85520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,27]]}},"URL":"https:\/\/doi.org\/10.4274\/mmj.galenos.2023.85520","relation":{},"ISSN":["2149-2042"],"issn-type":[{"value":"2149-2042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,27]]}}}